Index
Measure ID
Title
eMeasure ID
Measure Type
NQF ID
High Priority
Submission Methods
Risk Adjusted?
Registry Measure?
ACPGR3
Fixed-dose Combination of Hydralazine and Isosorbide Dinitrate Therapy for Self-identified Black or African American Patients with Heart Failure and LVEF <40% on ACEI or ARB and Beta-blocker Therapy
Process
Not Set True False
Not Set True False
Not Set True False
ACR7
Gout: Serum Urate Target
Process
Not Set True False
Not Set True False
Not Set True False
ACRad1
CT Colonography True Positive Rate
Outcome
Not Set True False
Not Set True False
Not Set True False
ACRad15
Report Turnaround Time: Radiography (modified)
(Inverse Measure)
Outcome
Not Set True False
Not Set True False
Not Set True False
ACRad16
Report Turnaround Time: Ultrasound (Excluding Breast US)
(Inverse Measure)
Outcome
Not Set True False
Not Set True False
Not Set True False
ACRad17
Report Turnaround Time: MRI
(Inverse Measure)
Outcome
Not Set True False
Not Set True False
Not Set True False
ACRad18
Report Turnaround Time: CT
(Inverse Measure)
Outcome
Not Set True False
Not Set True False
Not Set True False
ACRad19
Report Turnaround Time: PET
(Inverse Measure)
Outcome
Not Set True False
Not Set True False
Not Set True False
ACRad2
CT Colonography Clinically Significant Extracolonic Findings (Inverse Measure)
Outcome
Not Set True False
Not Set True False
Not Set True False
ACRad21
Lung Cancer Screening Cancer Detection Rate (CDR)
Outcome
Not Set True False
Not Set True False
Not Set True False
ACRad22
Lung Cancer Screening Positive Predictive Value (PPV)
Outcome
Not Set True False
Not Set True False
Not Set True False
ACRad23
Lung Cancer Screening Abnormal Interpretation Rate
Outcome
Not Set True False
Not Set True False
Not Set True False
Page 8 of 75
© 2024 - PremierOne Plus MIPS